BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34723213)

  • 1. Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assay.
    Varca AC; Casalena D; Auld D; Buhrlage SJ
    STAR Protoc; 2021 Dec; 2(4):100896. PubMed ID: 34723213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of selective deubiquitinase inhibitors.
    Varca AC; Casalena D; Chan WC; Hu B; Magin RS; Roberts RM; Liu X; Zhu H; Seo HS; Dhe-Paganon S; Marto JA; Auld D; Buhrlage SJ
    Cell Chem Biol; 2021 Dec; 28(12):1758-1771.e13. PubMed ID: 34129829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecules as tools for functional assessment of deubiquitinating enzyme function.
    Magin RS; Liu X; Felix A; Bratt AS; Chan WC; Buhrlage SJ
    Cell Chem Biol; 2021 Jul; 28(7):1090-1100. PubMed ID: 34089649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
    Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors.
    Ott CA; Baljinnyam B; Zakharov AV; Jadhav A; Simeonov A; Zhuang Z
    ACS Chem Biol; 2017 Sep; 12(9):2399-2407. PubMed ID: 28836754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening of histone deacetylases and determination of kinetic parameters using fluorogenic assays.
    Moreno-Yruela C; Olsen CA
    STAR Protoc; 2021 Mar; 2(1):100313. PubMed ID: 33659897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling the Activity of Deubiquitinating Enzymes Using Chemically Synthesized Ubiquitin-Based Probes.
    Leestemaker Y; de Jong A; Ovaa H
    Methods Mol Biol; 2017; 1491():113-130. PubMed ID: 27778285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Permeable Activity-Based Ubiquitin Probes Enable Intracellular Profiling of Human Deubiquitinases.
    Gui W; Ott CA; Yang K; Chung JS; Shen S; Zhuang Z
    J Am Chem Soc; 2018 Oct; 140(39):12424-12433. PubMed ID: 30240200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Assay for Characterizing Rpn11 Deubiquitinase Activity.
    Xie G; Dong KC; Worden EJ; Martin A
    Methods Mol Biol; 2023; 2591():79-100. PubMed ID: 36350544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.
    Schauer NJ; Magin RS; Liu X; Doherty LM; Buhrlage SJ
    J Med Chem; 2020 Mar; 63(6):2731-2750. PubMed ID: 31682427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Deubiquitinases in Cancer.
    Bednash JS; Mallampalli RK
    Methods Mol Biol; 2018; 1731():295-305. PubMed ID: 29318562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput compatible fluorescence resonance energy transfer-based assay to identify small molecule inhibitors of AMSH deubiquitinase activity.
    Arnst JL; Davies CW; Raja SM; Das C; Natarajan A
    Anal Biochem; 2013 Sep; 440(1):71-7. PubMed ID: 23747283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.
    Atkins SL; Motaib S; Wiser LC; Hopcraft SE; Hardy PB; Shackelford J; Foote P; Wade AH; Damania B; Pagano JS; Pearce KH; Whitehurst CB
    Antiviral Res; 2020 Jan; 173():104649. PubMed ID: 31711927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay Systems for Profiling Deubiquitinating Activity.
    Cho J; Park J; Kim EE; Song EJ
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
    Moghadasi SA; Moraes SN; Harris RS
    J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput MALDI-TOF Mass Spectrometry-Based Deubiquitylating Enzyme Assay for Drug Discovery.
    De Cesare V; Davies P
    Methods Mol Biol; 2023; 2591():123-134. PubMed ID: 36350546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Diubiquitin-Based FRET Probes To Quantify Ubiquitin Linkage Specificity of Deubiquitinating Enzymes.
    Geurink PP; van Tol BD; van Dalen D; Brundel PJ; Mevissen TE; Pruneda JN; Elliott PR; van Tilburg GB; Komander D; Ovaa H
    Chembiochem; 2016 May; 17(9):816-20. PubMed ID: 26996281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Deubiquitinase Substrates in Xenopus Egg Extract.
    Rossio V; Paulo JA; King RW
    Methods Mol Biol; 2023; 2591():219-236. PubMed ID: 36350551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Deubiquitinase Catalytic State Using a Structure-Based Approach.
    Zhang Z; Das C
    Methods Mol Biol; 2023; 2591():1-15. PubMed ID: 36350539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating inhibitor discovery for deubiquitinating enzymes.
    Chan WC; Liu X; Magin RS; Girardi NM; Ficarro SB; Hu W; Tarazona Guzman MI; Starnbach CA; Felix A; Adelmant G; Varca AC; Hu B; Bratt AS; DaSilva E; Schauer NJ; Jaen Maisonet I; Dolen EK; Ayala AX; Marto JA; Buhrlage SJ
    Nat Commun; 2023 Feb; 14(1):686. PubMed ID: 36754960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.